Choriogonadotropin Alfa Patent Expiration
Choriogonadotropin Alfa was first introduced by Emd Serono Inc
Choriogonadotropin Alfa Patents
Given below is the list of patents protecting Choriogonadotropin Alfa, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ovidrel | US6706681 | HCG liquid formulations |
Mar 16, 2021
(Expired) | Emd Serono |
| Ovidrel | US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun 16, 2015
(Expired) | Emd Serono |
Choriogonadotropin Alfa's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List